Beata Bode
Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015
Kollár A, Rothermundt C, Klenke F, Bode B, Baumhoer D, Arndt V, Feller A, NICER Working Group. Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015. Cancer Epidemiol 2019; 63:101596.
11.09.2019Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015
11.09.2019Cancer Epidemiol 2019; 63:101596
Kollár Attila, Rothermundt Christian, Klenke Frank, Bode Beata, Baumhoer Daniel, Arndt Volker, Feller Anita, NICER Working Group
A 49-year old female with multiple extra-axial tumors
Neidert M, Leske H, Frontzek K, Bode B, Capper D, Regli L, Rushing E. A 49-year old female with multiple extra-axial tumors. Brain Pathol 2017; 27:235-236.
01.01.2017A 49-year old female with multiple extra-axial tumors
01.01.2017Brain Pathol 2017; 27:235-236
Neidert Marian Christoph, Leske Henning, Frontzek Karl, Bode Beata, Capper David, Regli Luca, Rushing Elisabeth J
RANK Ligand Blockade with Denosumab in Combination with Sorafenib in Chemorefractory Osteosarcoma: A Possible Step Forward?
Cathomas R, Rothermundt C, Bode B, Fuchs B, von Moos R, Schwitter M. RANK Ligand Blockade with Denosumab in Combination with Sorafenib in Chemorefractory Osteosarcoma: A Possible Step Forward?. Oncology 2014; 88:257-260.
17.12.2014RANK Ligand Blockade with Denosumab in Combination with Sorafenib in Chemorefractory Osteosarcoma: A Possible Step Forward?
17.12.2014Oncology 2014; 88:257-260
Cathomas Richard, Rothermundt Christian, Bode Beata, Fuchs Bruno, von Moos Roger, Schwitter Michael
A rare periosteal diaphyseal lesion of the ulna
Erschbamer M, Bode B, Buck F, Fuchs B. A rare periosteal diaphyseal lesion of the ulna. Open Orthop J 2012; 6:8-10.
10.02.2012A rare periosteal diaphyseal lesion of the ulna
10.02.2012Open Orthop J 2012; 6:8-10
Erschbamer Matthias, Bode Beata, Buck Florian M, Fuchs Bruno
Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology
Savic S, Herman J, Clark D, Zlobec I, Schönegg R, Spieler P, Loosli H, Bode B, Herzog M, Barascud A, Grilli B, Franco N, Bubendorf L. Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology. Chest 2010; 138:137-44.
05.02.2010Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology
05.02.2010Chest 2010; 138:137-44
Savic Spasenija, Herman James G, Clark Douglas P, Zlobec Inti, Schönegg René, Spieler Peter, Loosli Heinz, Bode Beata, Herzog Michelle, Barascud Audrey de Vito, Grilli Bruno, Franco Noreli, Bubendorf Lukas
Prognostic factors for the malignant triton tumor of the head and neck
Terzic A, Bode B, Gratz K, Stöckli S. Prognostic factors for the malignant triton tumor of the head and neck. Head & neck 2009; 31:679-88.
01.05.2009Prognostic factors for the malignant triton tumor of the head and neck
01.05.2009Head & neck 2009; 31:679-88
Terzic Andrej, Bode Beata, Gratz Klaus W, Stöckli Sandro